SecBot SecBot
DEFA14A ·Filed Apr 23, 2026

AVNS

AVANOS MEDICAL, INC.
BULLISH
Impact 8/10
Horizonweeks Processed6mo ago SEC0001606498-26-000055
Proxy solicitation materials
Actionable Insight ▲ Bullish

Traders should monitor for the upcoming definitive proxy statement and special shareholder meeting date, which will provide details on voting mechanics and timing. A favorable vote would likely lead to closing of the acquisition, taking AVNS private and removing it from public trading.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$24.71
T+0 close · Apr 23, 2026 · via day close
Latest settled
+1.13%
T+60 · $24.99
Vs SPY
−3.89%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 23 $24.71entry
  2. T+1 · 7mo ago −0.20%α −0.99% · $24.66
  3. T+5 · 7mo ago −0.24%α −1.72% · $24.65
  4. T+20 · 6mo ago +0.12%α −4.51% · $24.74
  5. T+60 · 4mo ago +1.13%α −3.89% · $24.99
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Avanos Medical is soliciting shareholder approval for its acquisition by A-AV Holdco I, Inc., an entity affiliated with private equity firm American Industrial Partners (AIP), following a definitive merger agreement signed on April 13, 2026. This DEFA14A filing is part of the proxy process to secure stockholder votes for the transaction, which management positions as a strategic move to accelerate innovation and growth.

Key Financial Metrics

Vote
merger approval

Key Facts

  • Avanos Medical, Inc. is being acquired by A-AV Holdco I, Inc., a company affiliated with American Industrial Partners (AIP).
  • The merger agreement was signed on April 13, 2026, with shareholder approval being sought via this proxy filing.
  • The transaction is structured as a merger with AV MergerSub, Inc., a wholly-owned subsidiary of Parent.
  • Shareholders will vote on the proposed acquisition, a material corporate event requiring formal proxy solicitation under SEC rules.
  • Management, led by CEO David Pacitti, frames the deal as a strategic acceleration of innovation, investment, and growth.

Financial Impact

Transaction represents a full acquisition of Avanos, a $1.1B market cap company, though the specific deal value is not disclosed in this filing.

ownership_structureequity_dilutioncontrol_change

Risk Factors

  • Risk that closing conditions are not satisfied or waived, delaying or derailing the transaction.
  • Possibility of competing bids emerging, given the lack of disclosed termination fee specifics.
  • Potential termination of the merger agreement under circumstances requiring Avanos to pay a termination fee.

Market Snapshot

Exchange
NYSE
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001606498-26-000055
Document: 0001606498-26-000055-index-headers.html0001606498-26-000055
Document: 0001606498-26-000055-index.html0001606498-26-000055
Document: 0001606498-26-000055.txt0001606498-26-000055

Track record

7 reports on AVNS

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Jul 27, 202616w ago 25-NSE Neutral 5/10 Entry $24.99 No price data
  2. Jul 2, 202619w ago 8-K / DEFA14A Bullish 7/10 Entry $24.93 to $24.94 ▲ +0.04% −0.89% vs SPY
  3. Jun 10, 202622w ago DEFM14A Bullish 8/10 Entry $24.98 to $24.87 ▼ −0.44% −0.87% vs SPY
  4. May 5, 202627w ago DEFA14A Neutral 5/10 Entry $24.72 to $24.73 ▲ +0.04% −1.09% vs SPY
  5. Apr 23, 202629w ago DEFA14A Bullish 8/10 Viewing Entry $24.71 to $24.65 ▼ −0.24% −1.72% vs SPY
  6. Apr 14, 202630w ago DEFA14A Neutral 4/10 Entry $24.63 to $24.64 ▲ +0.04% −1.35% vs SPY
  7. Feb 26, 202637w ago 8-K Neutral 5/10 Entry $14.49 to $13.79 ▼ −4.83% −3.70% vs SPY
Showing 7 of 7

US Market Status

Market Closed · Opens in 6h 19m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 23, 2026